These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7700844)

  • 1. Oxytocin antagonist blocks the vasodepressor but not the vasopressor effect of neurohypophysial peptides in chickens.
    Robinzon B; Koike TI; Marks PA
    Peptides; 1994; 15(8):1407-13. PubMed ID: 7700844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. At low dose, arginine vasotocin has vasopressor rather than vasodepressor effect in chickens.
    Robinzon B; Koike TI; Marks PA
    Gen Comp Endocrinol; 1993 Jul; 91(1):105-12. PubMed ID: 8405886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arg8]vasotocin excites neurones in the dorsal vagal complex in vitro: evidence for an action through novel class(es) of CNS receptors.
    Ingram CD; Tolchard S
    J Neuroendocrinol; 1994 Aug; 6(4):415-22. PubMed ID: 7987372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of angiotensin-II in chickens.
    Robinzon B; Koike TI; Marks PA
    Br Poult Sci; 1995 Sep; 36(4):655-65. PubMed ID: 8590097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.
    Manning M; Kruszynski M; Bankowski K; Olma A; Lammek B; Cheng LL; Klis WA; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1989 Feb; 32(2):382-91. PubMed ID: 2913298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists.
    Manning M; Cheng LL; Klis WA; Balaspiri L; Olma A; Sawyer WH; Wo NC; Chan WY
    J Med Chem; 1995 May; 38(10):1762-9. PubMed ID: 7752199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological effects of arginine vasotocin and mesotocin in cockerels.
    Robinzon B; Koike TI; Neldon HL; Kinzler SL; Hendry IR; el Halawani ME
    Br Poult Sci; 1988 Sep; 29(3):639-52. PubMed ID: 3224294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats.
    Feuerstein G; Zerbe RL; Faden AI
    J Pharmacol Exp Ther; 1984 Feb; 228(2):348-53. PubMed ID: 6694114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of vasotocin stimulation of phosphoinositide turnover in frog adrenal gland.
    Larcher A; Delarue C; Homo-Delarche F; Kikuyama S; Kupryszewski G; Vaudry H
    Endocrinology; 1992 Jan; 130(1):475-83. PubMed ID: 1309345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A V1-type receptor for mediating the neurohypophysial hormone-induced ACTH release in trout pituitary.
    Pierson PM; Guibbolini ME; Lahlou B
    J Endocrinol; 1996 Apr; 149(1):109-15. PubMed ID: 8676042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of the biological effects of neurohypophysial peptides on seminiferous tubules.
    Harris GC; Nicholson HD
    J Endocrinol; 1998 Jan; 156(1):35-42. PubMed ID: 9496231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of arginine vasotocin vascular smooth muscle receptors in the trout (Oncorhynchus mykiss) in vitro.
    Conklin DJ; Smith MP; Olson KR
    Gen Comp Endocrinol; 1999 Apr; 114(1):36-46. PubMed ID: 10094857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of immunoreactive mesotocin and vasotocin during oviposition in chickens: relationship to oxytocic action of the peptides in vitro and peptide interaction with myometrial membrane binding sites.
    Koike TI; Shimada K; Cornett LE
    Gen Comp Endocrinol; 1988 Apr; 70(1):119-26. PubMed ID: 3371647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feeding response following central administration of mesotocin and arginine-vasotocin receptor agonists in chicks (Gallus gallus).
    Masunari K; Cline MA; Khan SI; Tachibana T
    Physiol Behav; 2016 Jan; 153():149-54. PubMed ID: 26545301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine vasotocin and a novel oxytocin-vasotocin-like material in plasma of human newborns.
    Ervin MG; Amico JA; Leake RD; Ross MG; Robinson AG; Fisher DA
    Biol Neonate; 1988; 53(1):17-22. PubMed ID: 3355867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurohypophysial hormones and steroidogenesis in the interrenals of Xenopus laevis.
    Kloas W; Hanke W
    Gen Comp Endocrinol; 1990 Nov; 80(2):321-30. PubMed ID: 1963609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of centrally administered arginine vasopressin on blood pressure in the conscious rabbit.
    Martin SM; Malkinson TJ; Veale WL; Pittman QJ
    Brain Res; 1985 Nov; 348(1):137-45. PubMed ID: 2933125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
    Champigneulle A; Siga E; Vassent G; Imbert-Teboul M
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frog glomerular vasotocin receptors resemble mammalian V1b receptors.
    Ammar A; Rajerison RM; Roseau S; Bloch-Faure M; Butlen D
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1198-208. PubMed ID: 7977846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.